Two-Year watch: tracking a Real-World treatment for a chronic throat condition
NCT ID NCT06695897
Summary
This study aims to learn how well the medication dupilumab works for people with eosinophilic esophagitis (EoE) in everyday life over two years. It will follow 150 patients in Germany who are already starting this treatment to see how it affects their symptoms, safety, and quality of life. The study is observational, meaning researchers will watch and collect information but will not change the patients' prescribed care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigational Site Number: 0000001
RECRUITINGDachau, Bavaria, 85221, Germany
Conditions
Explore the condition pages connected to this study.